Eslam Abourisha

Mr. Eslam Abourisha


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2024 in Journal of Orthopaedics
Verified
Journal Article
Closed access
EAEslam Abourisha
Eslam Abourisha
ASAnanth Srinivasan
Ananth Srinivasan
ABAhmed Barakat
Ahmed Barakat
HCHan Hong Chong
Han Hong Chong
HSHarvinder P. Singh
Harvinder P. Singh

28 November 2023 in Journal of Shoulder and Elbow Surgery
Verified
Journal Article
Closed access
SKSherif Ahmed Kamel
Sherif Ahmed Kamel
JSJenna Shepherd
Jenna Shepherd
AAAwf Al-Shahwani
Awf Al-Shahwani
EAEslam Abourisha
Eslam Abourisha
DMDivine Maduka
Divine Maduka
HSHarvinder Singh
Harvinder Singh

28 November 2023 in Journal of Orthopaedics
Verified
Journal Article
Closed access
EAEslam Abourisha
Eslam Abourisha
MSMohamed Sakr
Mohamed Sakr
ASAnanth Srinivasan
Ananth Srinivasan
HSHarvinder pal Singh
Harvinder pal Singh

22 May 2023 in Journal of Orthopaedics
Verified
Journal Article
Closed access
EAEslam Abourisha
Eslam Abourisha
ASAnanth Srinivasan
Ananth Srinivasan
ABAmit Bishnoi
Amit Bishnoi
SRSimon Rudge
Simon Rudge
ABAlistair Best
Alistair Best
UCUrjit Chatterji
Urjit Chatterji

1 April 2026 in Journal of Spine Surgery
Verified
Journal Article
Open access
PDF file
SASheweidin Aziz
Sheweidin Aziz
KAKrishan Almeida
Krishan Almeida
MAMaria Armaou
Maria Armaou
SGSCOOT Group
SCOOT Group
PBPartha Basu
Partha Basu
JDJoseph J. Dias
Joseph J. Dias
Background: Earlier diagnosis, advances in medical oncology and radiation modalities continue to improve cancer patients’ survival length, leading to a rise in metastatic disease and metastatic spinal cord compression (MSCC). Treatment approaches need a high level of individualisation, making management decisions for these patients challenging. Methods: A modified Delphi study with quantitative and qualitative analysis to identify thresholds for surgical intervention for MSCC patients and the factors underpinning those thresholds. A predefined expert panel was sent rounds of decision-making questionnaires on clinical vignettes of the most common primary tumours causing MSCC. The thresholds reached were based on RAND criteria and percentage agreement. Results: Twenty-four experts completed the first round, and 22 completed subsequent rounds. Experts had 312 years of experience managing MSCC patients. Spinal Instability Neoplastic Score (SINS) was the most used scoring system. The primary tumour, neurological function at presentation, functional status, and spinal lesion type were important in decision-making. Age and visceral metastasis were less important. Overall, 74% would not operate on patients paralysed at presentation, while 33% would operate within 24 hours from the onset of paralysis. The surgical intervention threshold was a visual analogue scale (VAS) of 6/10, with 82% expected to achieve pain relief. Conclusions: Treatment algorithms were constructed from the experts’ responses for each primary tumour type. Indications for surgery were spinal instability and a VAS of 6/10. Major factors influencing decision-making were prognosis and pain levels. Careful consideration should be given to lung, myeloma and unknown primaries.

28 September 2026 in Spine Deformity
Verified
Journal Article
Closed access
PDF file
EAEslam Abourisha
Eslam Abourisha
TTTanmay Talavia
Tanmay Talavia
GJGaurav Jha
Gaurav Jha
SASheweidin Aziz
Sheweidin Aziz